- GMP
About
Symeres provides integrated small-molecule drug discovery and development services from idea to IND for biopharma clients. It works across chemistry, biology, ADME-Tox, process development, CMC, and GMP manufacturing through connected teams in Europe and North America.
Services
Medicinal chemistry
Runs hit-to-lead, lead optimization, and preclinical candidate selection programs with SAR development, scaffold design, and compound synthesis.
Assays & in vitro testing
Synthetic chemistry
Provides custom synthesis, building blocks, intermediates, chiral and isotopic compounds, and scalable synthetic routes for discovery programs.
Assays & in vitro testing
Computational chemistry
Supports design and optimization of small molecules with computational methods integrated into chemistry programs.
Speciality chemistry
Supports chemistry needs for design, synthesis, and optimization of small molecules with specialty chemistry capabilities.
In vitro ADME
Performs in vitro ADME studies including physicochemical profiling, metabolic stability, metabolite profiling, CYP profiling, plasma protein binding, and permeability assays.
ADME, DMPK & toxicology
In vivo PK screening
Runs rapid in vivo pharmacokinetic screening studies to assess exposure, clearance, bioavailability, half-life, and tissue distribution.
ADME, DMPK & toxicology
Bioassays
Provides in vitro bioassays and mechanistic profiling for target validation, potency, biomarkers, mechanism of action, and combination studies.
Assays & in vitro testing
Bioinformatics
Analyzes biological data to support biomarker discovery, target validation, translational research, patient selection, and mechanism-of-action interpretation.
Drug delivery
Designs and develops lipid and polymer systems to improve solubility, stability, and targeted delivery of therapeutics.
Polymers
Designs, synthesizes, characterizes, and scales polymer-based drug delivery systems and polymer-drug conjugates.
Lipids
Designs, synthesizes, and manufactures lipids for nucleic acid delivery and related drug delivery applications.
Process development
Develops scalable, phase-appropriate chemical processes, including route scouting, optimization, flow chemistry, biocatalysis, and chiral separation.
Preclinical drug substance manufacturing
Converts medicinal chemistry routes into reproducible large-scale processes and supplies non-GMP material for preclinical and IND-enabling studies.
CDMO: development & manufacturing
GMP starting materials
Manufactures GMP starting materials and advanced intermediates for drug substance preparation with batch manufacturing from 10 L to 1,000 L.
CDMO: development & manufacturing
GMP manufacturing
Provides GMP manufacturing of drug substances, APIs, and intermediates for preclinical development through clinical supply.
CDMO: development & manufacturing
Clinical formulation development and analytical services
Provides formulation and analytical support for complex molecules with regulatory-ready documentation for clinical trial material delivery.
Drug product
Develops clinical drug products such as capsules and tablets to support IND submission and early clinical use.
Solid state chemistry
Supports drug development with solid-state chemistry expertise connected to process development and manufacturing.
ADME-Tox
Provides in vitro ADME-Tox and related DMPK studies for small molecules and other modalities to identify risks early and support IND preparation.
ADME, DMPK & toxicology
Chemistry
Medicinal, computational, synthetic, and specialty chemistry for design, synthesis, and optimization of small molecules, including SAR development, structure-based design, parallel synthesis, and route optimization.
Assays & in vitro testing
ADME
In vitro and in vivo ADME studies to define pharmacokinetic and metabolic profiles and support candidate selection.
ADME, DMPK & toxicology
Biology
Assays for target validation, potency, biomarkers, and mechanism of action studies using in vitro enzymatic and cell-based systems with bioinformatics support.
Assays & in vitro testing
Preclinical
Support from candidate selection through IND/IMPD with regulatory-ready data and documentation.
Formulation and analytical development
Clinical formulation development, analytical development, analytical testing, stability studies, and clinical trial material manufacturing.
Spray Drying
Spray drying capability for formulation development and solubility optimization, including amorphous solid dispersions and particle engineering.
In vitro toxicology
In vitro toxicology services as part of drug discovery support.
ADME, DMPK & toxicology
- Lead time
- Fast turnaround
Capabilities
As they state on their website or in their listing.
- Processes
- Small molecule · ADC · Peptide · Oligonucleotide · mRNA · ADME · In vivo · PK/PD · Analytical development · Toxicology · ADCs · Small molecules
1 more
Process development - Capacity
- 600+ scientists · 9 global sites · Batch manufacturing from 10 L to 1,000 L · 2–250 g · Grams to kilograms · >260 well-characterized tumor cell lines · More than 270 annotated cell lines · 10 L to 1,000 L batch manufacturing capabilities · Laboratory-scale spray drying · Pilot-scale spray drying
- Offers
- Custom synthesis
- Scales
- Gram · Kilogram
- Data supplied
- LC-MS
Equipment
- LC-MS/MS
- UPLC-HR/MS
- LC-HR/MS
- qPCR
- ELISA
- DILIscope
- GPC
- SEC
- TFF
Materials
- Insect cells
- Primary human cells
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
AAALACSelf-reported
Scope: in vivo PK screening facilities
Company
- Type
- CRO
- Team
- 600+ scientists
Locations
- Address
- 1002 Eastpark Blvd Cranbury, NJ 08512 United States
- Sites
- Netherlands, Netherlands · Finland, Finland · Czech Republic, Czech Republic · Europe, Europe · North America, North America · Nijmegen, The Netherlands · Breda, The Netherlands · Cranbury, NJ, USA
- Serves
- Europe, North America, transatlantic
Contacts
- General enquiry
- info@symeres.com on their site
Public records
Similar labs
Work here? Claim this listing